Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation

Journal of Thoracic Oncology

Volumn 8, Issue 12, 2013, Pages 1484-1491

  Zhang, Xiaochun ^a,b   Lin, Steven H ^a   Fang, Bingliang ^a   Gillin, Michael ^a   Mohan, Radhe ^a   Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cancer stem cells; Non small cell lung cancer; Photon therapy; Proton therapy; Treatment resistance

Indexed keywords

BETA CATENIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; PACLITAXEL; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; PROTON;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR PARAMETERS; CLINICAL EFFECTIVENESS; CLONOGENESIS; CONTROLLED STUDY; COXSACKIE VIRUS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PHOTON THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON THERAPY; RADIATION DOSE; RADIOSENSITIVITY; TUMOR RECURRENCE; TUMOR SPHERE FORMATION; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PHOTON; RADIATION RESPONSE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; PACLITAXEL; PHOTONS; PROTONS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 84892181847     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182a5fdcb     Document Type: Article

References (24)

1. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780-783.
2. Zhang X, Fang B, Mohan R, Chang JY. Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer. Radiother Oncol 2012;105:250-257.
3. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 2008;8:545-554.
4. Brunner TB, Kunz-Schughart LA, grosse-gehling P, Baumann M. Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol 2012;22:151-174.
5. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-284.
6. Krause M, Yaromina A, Eicheler W, Koch U, Baumann M. Cancer stem cells: targets and potential biomarkers for radiotherapy. Clin Cancer Res 2011;17:7224-7229.
7. Mihatsch J, Toulany M, Bareiss PM, et al. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro. Radiother Oncol 2011;99:300-306.
8. Nguyen gH, Murph MM, Chang JY. Cancer stem cell radioresistance and enrichment: where frontline radiation therapy may fail in lung and esophageal cancers. Cancers (Basel) 2011;3:1232-1252.
9. Chang JY, Zhang X, Wang X, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1087-1096.
10. Chang JY, Komaki R, Wen HY, et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;80:1350-1357.
11. Chang JY, Komaki R, Lu C, et al. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer 2011;117:4707-4713.
12. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007;25:953-964.
13. Wambersie A. RBE, reference RBE, and clinical RBE: applications of these concepts in hadron therapy. Strahlenther Onkol 1999;175:39-43.
14. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-421.
15. Finnberg N, Wambi C, Ware JH, Kennedy AR, El-Deiry WS. gamma-radiation (gR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo. Cancer Biol Ther 2008;7:2023-2033.
16. Ogata T, Teshima T, Kagawa K, et al. Particle irradiation suppresses meta-static potential of cancer cells. Cancer Res 2005;65:113-120.
17. Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin Cancer Res 2008;14:2813-2823.
18. Zhang X, Cheung RM, Komaki R, Fang B, Chang JY. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin Cancer Res 2005;11:6657-6668.
19. Chang JY, Zhang X, Komaki R, Cheung R, Fang B. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal cancer. Int J Radiat Oncol Biol Phys 2006;64:1482-94.
20. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994;65:27-33.
21. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007;128:325-339.
22. Tothova Z, gilliland Dg. A radical bailout strategy for cancer stem cells. Cell Stem Cell 2009;4:196-197.
23. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777-1785.
24. Pietro CD, Tabbi g, Ragusa M, et al. Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis 2006;11:57-66.